{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:08:47Z","timestamp":1777896527987,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002569","name":"Wonkwang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27831-y","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:21:01Z","timestamp":1766492461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SARS-CoV-2 animal vaccine with cross-protection against Wuhan strain and delta variant"],"prefix":"10.1038","volume":"15","author":[{"given":"Eulhae","family":"Ga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongkwan","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaehyun","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjoo","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Woo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daesub","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Soo","family":"Lyoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woonsung","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"27831_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/clinpract11040093","volume":"11","author":"S Shiehzadegan","year":"2021","unstructured":"Shiehzadegan, S., Alaghemand, N., Fox, M. & Venketaraman, V. Analysis of the delta variant B. 1.617. 2 COVID-19. Clin. Pract. 11, 778\u2013784 (2021).","journal-title":"Clin. Pract."},{"key":"27831_CR2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1080\/14760584.2021.1976153","volume":"20","author":"L Bian","year":"2021","unstructured":"Bian, L. et al. Impact of the delta variant on vaccine efficacy and response strategies. Expert Rev. Vaccines. 20, 1201\u20131209 (2021).","journal-title":"Expert Rev. Vaccines"},{"key":"27831_CR3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/tbed.13791","volume":"68","author":"G Zhang","year":"2021","unstructured":"Zhang, G. et al. Animal coronaviruses and SARS-CoV\u20102. Transbound. Emerg. Dis. 68, 1097\u20131110 (2021).","journal-title":"Transbound. Emerg. Dis."},{"key":"27831_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.micro.51.1.151","volume":"51","author":"E Domingo","year":"1997","unstructured":"Domingo, E. & Holland, J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51, 151\u2013178 (1997).","journal-title":"Annu. Rev. Microbiol."},{"key":"27831_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1098\/rstb.2004.1481","volume":"359","author":"RM Bush","year":"2004","unstructured":"Bush, R. M. Influenza as a model system for studying the cross\u2013species transfer and evolution of the SARS coronavirus. Philosophical Trans. Royal Soc. Lond. Ser. B: Biol. Sci. 359, 1067\u20131073 (2004).","journal-title":"Philosophical Trans. Royal Soc. Lond. Ser. B: Biol. Sci."},{"key":"27831_CR6","first-page":"158","volume":"3","author":"W Ma","year":"2008","unstructured":"Ma, W., Kahn, R. E. & Richt, J. A. The pig as a mixing vessel for influenza viruses: human and veterinary implications. J. Mol. Genetic Medicine: Int. J. Biomedical Res. 3, 158 (2008).","journal-title":"J. Mol. Genetic Medicine: Int. J. Biomedical Res."},{"key":"27831_CR7","doi-asserted-by":"crossref","unstructured":"McLean, A. R., May, R. M., Pattison, J. & Weiss, R. SARS: a case study in emerging infections. (2005).","DOI":"10.1093\/acprof:oso\/9780198568193.001.0001"},{"key":"27831_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.chom.2015.09.013","volume":"18","author":"G Wong","year":"2015","unstructured":"Wong, G. et al. MERS, SARS, and ebola: the role of super-spreaders in infectious disease. Cell. Host Microbe. 18, 398\u2013401 (2015).","journal-title":"Cell. Host Microbe"},{"key":"27831_CR9","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1128\/JVI.01394-09","volume":"84","author":"RL Graham","year":"2010","unstructured":"Graham, R. L. & Baric, R. S. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J. Virol. 84, 3134\u20133146 (2010).","journal-title":"J. Virol."},{"key":"27831_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41392-021-00704-2","volume":"6","author":"Z Niu","year":"2021","unstructured":"Niu, Z. et al. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding. Signal. Transduct. Target. Therapy. 6, 284 (2021).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"27831_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/BF01309861","volume":"140","author":"W Jia","year":"1995","unstructured":"Jia, W., Karaca, K., Parrish, C. & Naqi, S. A novel variant of avian infectious bronchitis virus resulting from recombination among three different strains. Arch. Virol. 140, 259\u2013271 (1995).","journal-title":"Arch. Virol."},{"key":"27831_CR12","unstructured":"Lai, M. M. in seminars in Virology. 381."},{"key":"27831_CR13","first-page":"410","volume":"19","author":"JT Ortega","year":"2020","unstructured":"Ortega, J. T., Serrano, M. L., Pujol, F. H. & Rangel, H. R. Role of changes in SARS-CoV-2 Spike protein in the interaction with the human ACE2 receptor: an in Silico analysis. EXCLI J. 19, 410 (2020).","journal-title":"EXCLI J."},{"key":"27831_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/cr.2016.152","volume":"27","author":"M Gui","year":"2017","unstructured":"Gui, M. et al. Cryo-electron microscopy structures of the SARS-CoV Spike glycoprotein reveal a prerequisite conformational state for receptor binding. Cell Res. 27, 119\u2013129 (2017).","journal-title":"Cell Res."},{"key":"27831_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"27831_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-020-00318-0","volume":"5","author":"F Yu","year":"2020","unstructured":"Yu, F. et al. Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2. Signal. Transduct. Target. Therapy. 5, 212 (2020).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"27831_CR17","doi-asserted-by":"publisher","first-page":"108215","DOI":"10.1016\/j.intimp.2021.108215","volume":"101","author":"A Cristiano","year":"2021","unstructured":"Cristiano, A. et al. Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic\/symptomatic patients and vaccinated subjects. Int. Immunopharmacol. 101, 108215 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"27831_CR18","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.ajem.2020.05.015","volume":"38","author":"KH Chan","year":"2020","unstructured":"Chan, K. H., Farouji, I., Hanoud, A. A. & Slim, J. Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19). Am. J. Emerg. Med. 38, 1548\u2013e1541 (2020).","journal-title":"Am. J. Emerg. Med."},{"key":"27831_CR19","doi-asserted-by":"publisher","first-page":"107070","DOI":"10.1016\/j.actatropica.2023.107070","volume":"249","author":"C Piewbang","year":"2024","unstructured":"Piewbang, C. et al. Natural SARS-CoV-2 infection in dogs: determination of viral loads, distributions, localizations, and pathology. Acta Trop. 249, 107070 (2024).","journal-title":"Acta Trop."},{"key":"27831_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13567-021-00897-y","volume":"52","author":"AJ Peris\u00e9-Barrios","year":"2021","unstructured":"Peris\u00e9-Barrios, A. J. et al. Humoral responses to SARS-CoV-2 by healthy and sick dogs during the COVID-19 pandemic in Spain. Vet. Res. 52, 22 (2021).","journal-title":"Vet. Res."},{"key":"27831_CR21","doi-asserted-by":"publisher","first-page":"8403","DOI":"10.1038\/s41598-022-12468-y","volume":"12","author":"W Jairak","year":"2022","unstructured":"Jairak, W. et al. SARS-CoV-2 delta variant infection in domestic dogs and cats, Thailand. Sci. Rep. 12, 8403 (2022).","journal-title":"Sci. Rep."},{"key":"27831_CR22","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3201\/eid2904.221727","volume":"29","author":"KS Lyoo","year":"2023","unstructured":"Lyoo, K. S. et al. Experimental infection and transmission of SARS-CoV-2 delta and Omicron variants among beagle dogs. Emerg. Infect. Dis. 29, 782 (2023).","journal-title":"Emerg. Infect. Dis."},{"key":"27831_CR23","doi-asserted-by":"publisher","first-page":"2068883","DOI":"10.1080\/21645515.2022.2068883","volume":"18","author":"M Dhawan","year":"2022","unstructured":"Dhawan, M. et al. Delta variant (B. 1.617. 2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions. Hum. Vaccines Immunotherapeutics. 18, 2068883 (2022).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"27831_CR24","doi-asserted-by":"publisher","first-page":"815978","DOI":"10.3389\/fvets.2022.815978","volume":"9","author":"K Tabynov","year":"2022","unstructured":"Tabynov, K. et al. A Spike protein-based subunit SARS-CoV-2 vaccine for pets: safety, immunogenicity, and protective efficacy in juvenile cats. Front. Veterinary Sci. 9, 815978 (2022).","journal-title":"Front. Veterinary Sci."},{"key":"27831_CR25","doi-asserted-by":"crossref","unstructured":"Galkina, T., Nesterov, A., Borisov, A., Chvala, I. & Kononov, A. Development of Carnivac-Cov vaccine against coronavirus infection (COVID-19) in carnivores. Vet. Sci. Today, 82\u201387 (2021).","DOI":"10.29326\/2304-196X-2021-2-37-82-87"},{"key":"27831_CR26","doi-asserted-by":"publisher","first-page":"e2210780","DOI":"10.1001\/jamanetworkopen.2022.10780","volume":"5","author":"K Furukawa","year":"2022","unstructured":"Furukawa, K. et al. Assessment of neutralizing antibody response against SARS-CoV-2 variants after 2 to 3 doses of the BNT162b2 mRNA COVID-19 vaccine. JAMA Netw. Open. 5, e2210780\u2013e2210780 (2022).","journal-title":"JAMA Netw. Open."},{"key":"27831_CR27","unstructured":"Fielder, S. Hematology reference ranges. Merck veterinary manual.  (accessed 19 November 2017); http:\/\/www.merckvetmanual.com\/appendixes\/reference-guides\/hematologic-reference-ranges"},{"key":"27831_CR28","unstructured":"Thrall, M. A., Weiser, G., Allison, R. W. & Campbell, T. W. Veterinary hematology, Clinical chemistry, and Cytology (Wiley, 2022)."},{"key":"27831_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1939-165X.2004.tb00347.x","volume":"33","author":"A Moritz","year":"2004","unstructured":"Moritz, A., Fickenscher, Y., Meyer, K., Failing, K. & Weiss, D. J. Canine and feline hematology reference values for the ADVIA 120 hematology system. Vet. Clin. Pathol. 33, 32\u201338 (2004).","journal-title":"Vet. Clin. Pathol."},{"key":"27831_CR30","first-page":"1207","volume":"33","author":"AM Barger","year":"2003","unstructured":"Barger, A. M. The complete blood cell count: a powerful diagnostic tool. Veterinary Clinics: Small Anim. Pract. 33, 1207\u20131222 (2003).","journal-title":"Veterinary Clinics: Small Anim. Pract."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27831-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27831-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27831-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T01:03:25Z","timestamp":1766538205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27831-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27831"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27831-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experiments were conducted in accordance with the regulations of the care and use of laboratory animal guidelines of Jeonbuk National University and were approved by the Institutional Animal Care and Use Committee (approval number: NON2022-05) and certified by the Korea Disease Control and Prevention Agency (certification number KCDC-15-3-02). The experimental protocols requiring biosafety were approved by the Institutional Biosafety Committee of Jeonbuk National University (approval number: JBNU 2022\u201311\u2009\u2212\u2009001). The clinical trials complied with the current laws of Korea. Animal care and treatment were conducted in accordance with the guidelines established by the Institutional Animal Care and Use Committee (P22-001). The study is reported in accordance with ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"44343"}}